Why the study?
Does teprotide injection reverse delayed cerebral vasospasm in dogs with experimental subarachnoid hemorrhage?
Does teprotide injection reverse delayed cerebral vasospasm in dogs with experimental subarachnoid hemorrhage?
Angiotensin-converting enzyme inhibition with teprotide can partially or totally reverse experimental delayed cerebral vasospasm in a dog model of subarachnoid hemorrhage.
Answers are grounded in this paper and cite their sources.
Teprotide merits exploration for cerebral vasospasm; leaves open translation from canine models to human subarachnoid hemorrhage.
Delayed cerebral vasospasm is an important determinant of the clinical outcome after subarachnoid hemorrhage, but its prevention and treatment has met with limited success. Since cerebral arteries were found to be sensitive to the vasoconstrictor effect of angiotensin II, the possibility of angiotensin's contribution to this vasospasm was investigated. Delayed cerebral arterial spasm was documented angiographically 72 hours after introduction of blood in the subarachnoid space of dogs. Following injection of the angiotensin-converting enzyme inhibitor, teprotide, repeat cineangiograms at 30, 60, and 90 minutes demonstrated partial or total release of spasm of the basilar artery and its branches. It is concluded that angiotensin II participates in the delayed cerebral vasospasm after hemorrhage, and that angiotensin inhibition may release the spasm and prevent cerebral ischemia.
No takes yet. Share an insight, caveat, or question.
Gavras et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: